SML Genetree participated in the ‘ESCMID Global exhibition (formerly ECCMID)’, held in Vienna, Austria, to promote its respiratory virus and gastrointestinal infection diagnostic product lines, accelerating its efforts to expand into the global market.
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is the world’s largest academic and industrial exhibition in the field of infectious diseases and clinical microbiology. The event brings together diagnostic companies, research institutions, and healthcare professionals from around the world to share the latest technologies and research outcomes, while fostering collaboration across industries.
At the exhibition, SML Genetree actively showcased its differentiated technologies, focusing on its gastrointestinal infection diagnostic products, which are expected to receive CE-IVDR certification soon. The company highlighted the products’ accuracy, speed, and user-friendliness. It also held numerous business meetings to strengthen relationships with existing partners in Europe and to explore new global collaborations.
Dongsoo Lee, CEO of SML Genetree, stated, “Through our participation in ESCMID Global exhibition, we were able to effectively demonstrate the competitiveness of our technologies and products in the European and global markets. Based on the upcoming CE-IVDR certification, we will accelerate our entry into the European market and actively pursue partnership opportunities in the Middle East, Asia, South America, and beyond.”
SML Genetree expressed its commitment to continuously developing innovative solutions for infectious disease diagnostics and to becoming a global leader in the diagnostics industry.
Excerpted from https://www.pharmnews.com/news/articleView.html?idxno=259777 | 2025.04.25
SML Genetree participated in the ‘ESCMID Global exhibition (formerly ECCMID)’, held in Vienna, Austria, to promote its respiratory virus and gastrointestinal infection diagnostic product lines, accelerating its efforts to expand into the global market.
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is the world’s largest academic and industrial exhibition in the field of infectious diseases and clinical microbiology. The event brings together diagnostic companies, research institutions, and healthcare professionals from around the world to share the latest technologies and research outcomes, while fostering collaboration across industries.
At the exhibition, SML Genetree actively showcased its differentiated technologies, focusing on its gastrointestinal infection diagnostic products, which are expected to receive CE-IVDR certification soon. The company highlighted the products’ accuracy, speed, and user-friendliness. It also held numerous business meetings to strengthen relationships with existing partners in Europe and to explore new global collaborations.
Dongsoo Lee, CEO of SML Genetree, stated, “Through our participation in ESCMID Global exhibition, we were able to effectively demonstrate the competitiveness of our technologies and products in the European and global markets. Based on the upcoming CE-IVDR certification, we will accelerate our entry into the European market and actively pursue partnership opportunities in the Middle East, Asia, South America, and beyond.”
SML Genetree expressed its commitment to continuously developing innovative solutions for infectious disease diagnostics and to becoming a global leader in the diagnostics industry.
Excerpted from https://www.pharmnews.com/news/articleView.html?idxno=259777 | 2025.04.25